Last reviewed · How we verify

NCT06988111

Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI)

Not yet recruiting NA Last updated 23 May 2025
What this trial tests

NA trial testing BIPAP in Respiratory Failure Without Hypercapnia in 180 participants. Not yet recruiting.

Timeline
1 July 2025
Primary endpoint
1 July 2026
1 December 2026

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment180
Start date1 July 2025
Primary completion1 July 2026
Estimated completion1 December 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

18 and older, any sex, with Respiratory Failure Without Hypercapnia or Respiratory Failure With Hypercapnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative respiratory failure (PORF) remains a critical driver of morbidity, mortality, and incremental care costs in surgical populations. Traditional escalation often involves invasive mechanical ventilation, which is associated with ventilator-associated pneumonia (VAP), prolonged intensive care unit (ICU) stays, and increased resource burden.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of BIPAP

Trials testing the same drug.

Other recruiting trials for Respiratory Failure Without Hypercapnia

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06988111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing